✦ LIBER ✦

PUK1 INCIDENCE AND COST OF ADVERSE EVENTS (AES) IN PATIENTS WITH RENAL CELL CARCINOMA (RCC) TREATED WITH ANGIOGENESIS INHIBITORS (AIS)

✍ Scribed by E Dial; MS Duh; L Antras; D Rodermund; MP Neary; TK Choueiri; WK Oh

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN51 HEALTH CARE COSTS ASSOCIATED WITH

✍ K Chen; SP Sarda; L Antràs; S Whittemore; A Luka; P Ramamurthy; J Scott; B Fortn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN50 COSTS OF TREATMENT WITH ANGIOGENES

✍ WK Oh; DF McDermott; MS Duh; L Antràs; K Chen; SP Sarda; A Luka; S Whittemore; P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB